Kesimpta (Ofatumumab) Pregnancy Registry

Clinical trial NCT05634967 · RECRUITING

Trial details

NCT number: NCT05634967
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Multiple Sclerosis Pregnancy

Start date: 2023-01-05
Primary completion: 2033-02-28
Enrollment: 725

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.